The [alpha]Gal HyperAcute® Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural [alpha]Gal-Mediated Zoonotic Blockade

The αGal HyperAcute® Technology exploits a robust zoonotic blockade to enhance potency of antiviral vaccines. Naturally acquired immunity against the common αGal epitope [galactose-alpha(1,3)-galactose-beta(1,4) N -acetylglucosamine-R (Gal-α(1,3)-Gal-β(1,4)-GlcNAc-R)] is facilitated by the loss of a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zoonoses and public health 2009-08, Vol.56 (6-7), p.391
Hauptverfasser:	Mandell, R B, Flick, R, Staplin, W R, Kaniewski, L D, Carzoli, A K, Manuszak, R P, Wang, J, Rossi, G R, Vahanian, N N, Link, C J
Format:	Artikel
Sprache:	eng
Schlagworte:	Technology Vaccines Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!